Precision BioSciences, Inc. (DTIL) vs Eledon Pharmaceuticals, Inc. (ELDN)
A side-by-side comparison of Precision BioSciences, Inc. and Eledon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DTIL
Precision BioSciences, Inc.
$6.31HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ELDN
Eledon Pharmaceuticals, Inc.
$2.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — DTIL vs ELDN
growth of $100 · dividends reinvested · last 8yDTIL -98.8% (-42.4%/yr)ELDN -96.5% (-34.2%/yr)ELDN compounded faster over this window
DTIL ELDN
DTIL vs ELDN: by the numbers
- •ELDN is the larger company ($193M vs $174M market cap).
- •Both run net losses; ELDN's is the smaller (0.00% vs -117.04% net margin).
Metrics side by side
Valuation
| Metric | DTIL | ELDN |
|---|---|---|
| P/S ratio | 3.87 | N/A |
| P/B ratio | 3.85 | 5.85 |
Profitability
| Metric | DTIL | ELDN |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -152.19% | 0.00% |
| Net margin | -117.04% | 0.00% |
| ROE | -116.42% | -136.83% |
| ROIC | -30.23% | -74.02% |
Growth (annualized)
| Metric | DTIL | ELDN |
|---|---|---|
| Revenue CAGR (5Y) | 7.13% | N/A |
| Total return CAGR (5Y) | -54.84% | -15.17% |
Frequently asked
- How have DTIL and ELDN total returns compared?
- Over the past 5 years, DTIL delivered -54.84% and ELDN delivered -15.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.